Establishment Labs (NASDAQ:ESTA) Trading 4.9% Higher - Still a Buy?

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) shares shot up 4.9% during mid-day trading on Monday . The company traded as high as $34.87 and last traded at $35.08. 287,926 shares changed hands during trading, a decline of 55% from the average session volume of 638,589 shares. The stock had previously closed at $33.43.

Wall Street Analysts Forecast Growth

Separately, Stephens reiterated an "overweight" rating and set a $52.00 target price on shares of Establishment Labs in a report on Thursday. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $57.40.

Establishment Labs Stock Up 16.8 %

The company's fifty day simple moving average is $37.37 and its 200-day simple moving average is $41.33. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The firm has a market capitalization of $1.18 billion, a PE ratio of -16.22 and a beta of 1.12.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The company had revenue of $44.51 million during the quarter, compared to analysts' expectations of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. On average, analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Hedge Funds Weigh In On Establishment Labs

Several hedge funds have recently made changes to their positions in the company. Brown Advisory Inc. grew its stake in Establishment Labs by 23.1% during the 4th quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company's stock valued at $107,729,000 after purchasing an additional 438,057 shares during the last quarter. Capital Research Global Investors boosted its position in Establishment Labs by 29.3% in the fourth quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock valued at $88,064,000 after buying an additional 433,484 shares during the last quarter. Findell Capital Management LLC boosted its position in Establishment Labs by 28.5% in the fourth quarter. Findell Capital Management LLC now owns 1,346,480 shares of the company's stock valued at $62,032,000 after buying an additional 298,380 shares during the last quarter. William Blair Investment Management LLC increased its holdings in Establishment Labs by 44.1% in the 4th quarter. William Blair Investment Management LLC now owns 812,825 shares of the company's stock worth $37,447,000 after buying an additional 248,888 shares during the period. Finally, Rice Hall James & Associates LLC raised its position in Establishment Labs by 10.7% during the 3rd quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company's stock worth $34,326,000 after buying an additional 76,959 shares during the last quarter. 72.91% of the stock is owned by institutional investors and hedge funds.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.